JAKARTA - Finance Minister Sri Mulyani Indrawati said that imports of 1.2 million Sinovac vaccines from China by Indonesia have received import duty and tax free facilities.

This fiscal facility is listed in the Minister of Finance Regulation (PMK) Number 188 / PMK.04 / 2020. Through this regulation, the government provides facilities for the import of vaccines, vaccine raw materials and equipment needed in vaccine production, as well as equipment for vaccination.

"The facilities that we provide exemption from import and / or excise are not subject to PPN, PPNBM and exemption from PPh article 22 tax collection. The value of granting fiscal facilities obtained from the importation of this vaccine is equivalent to IDR 50.95 billion," he said at the Press Conference for the Arrival of the COVID-19 Vaccine. , Monday, December 7th.

This facility is provided to the Central Government, Local Government, BPOM, Legal Entities, or Non-Legal Entities who have been assigned or appointed by the Ministry of Health.

Of the total excise and tax incentives, Sri Mulyani noted that the exemption from import duty reached Rp. 14.56 billion and tax for imports of Rp. 36.39 billion.

According to excise documents, the number of vaccines reached 1.2 million vials 1 dose and 568 vials 1 dose for test samples.

"Fulfillment of administrative requirements has been carried out by PT Bio Farma which was appointed by the Ministry of Health as an importer," he explained.

In addition, the government also provides facilities in the form of procedural facilities for releasing goods with rush handling services, by submitting applications and submitting complementary customs documents and submitting guarantees.

"Starting from PIB to releasing goods, which is a maximum of 3 days, is now starting to accelerate. Last night, when we monitored the goods (vaccines) arriving in Cengkareng, they were immediately examined," he said.


The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)